We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current 0I6N market cap is 0. The company's latest EPS is RON and P/E is N/A.
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Total Revenue | 560.81M | 571.75M | 718.87M | 774.15M | 958.85M |
| Operating Income | 46.71M | 73.35M | 116.05M | 89.51M | 184.49M |
| Net Income | 43.75M | 65.64M | 105.75M | 99.47M | 192.62M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Total Assets | 1.02B | 1.03B | 1.05B | 1.21B | 1.5B |
| Total Liabilities | 315.91M | 247.9M | 158.83M | 205.82M | 308.24M |
| Total Equity | 702M | 785.36M | 890.77M | 999.36M | 1.19B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| RON (RON) | RON (RON) | RON (RON) | RON (RON) | RON (RON) | |
| Operating | -20.87M | 44.14M | 190.64M | 20.59M | 14.18M |
| Investing | -25.15M | -15.8M | -16.36M | -66.68M | 9.25M |
| Financing | 29.39M | -10.1M | -4.69M | -5.32M | -7.32M |
| Market Cap | 0 |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 697.02M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0 (0%) |
| Company Name | Zentiva Sa |
| Address |
50 theodor pallady blvd bucharest 336206 |
| Website | https://www.zentiva.ro |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
